U T I L I T Y O F CHROMOGRANIN
CgA is a 49 kilodalton peptide produced by a variety ofendocrine and neuroendocrine tissues and secreted with tissue-specific hormones. We present a family with apparent isolated familial pheochromocytoma i n which CgA has served as auseful marker for the identification of affected asymptomatic family members. There was a family history of sudden death i n a maternal uncle with subsequent identification of a pheochromocytoma on autopsy. The index case presented with a history of hypertension during a surgical procedure. Elevated urinary catecholamines i n this child were associated with bilateral periadrenal masses on MRI. A left periadrenal pheochromocytoma was removed at the time of surgery. Posioperatively, CgA was 30.8 n g l m L ( N L <50 ng/mL) associated with normal urinary catecholamines. Screening i n 8 of 13 family members revealed elevation o f CgA (>SO ng/mL) i n 5 (63%). Subsequent evaluation in selected family members revealed the presence of a retinal hemangioblastoma i n the mother of the index case; elevation of CgA (130 ngImL) in the maternal grandmother who is hypertensive with elevated urinary catecholamines; elevation of CgA (184 ng/mL) and urinary catecholamines i n a maternal cousin; elevation of CgA (487 ng/mL) and urinary calecholamines associated with hypertension and bilateral extra-adrenal pheochromocytomas in another maternal cousin. A l l subjects were asymptomatic prior to their identification by the screening methods employed here. Other than the retinal hemangioblastoma no other associated solid or vascular tumors have been identified during screening. This family demonstrates the benefit o f CgA as a screening tool i n identifying family members who are at risk for pheochromocytoma. Both salt-losing and non-salt-loslng 21-hydroxylase detlclency have been associated wfth a deleterious conversion event at nucfeotlde 655 (A or C In CYP21) to !lie CYP2lP sequence (G) which mod~f~es mRNAspllc~ng lead~ng to an elongaledtranslatfon product w~th altered enzyme actlvlty (PNAS 1988, 85.7486) To determlne 1 1 the DNA blnding reglon for acAMP-dependent adrenal speclflc nuclear TF (JBC 1991.266 11199) could accounlforth~s phenotypic heterogeneity, we determined the sequence ol this functionaliy conserved reglon (-134 to -122) In 3 patlents (2 salt-losing. 1 non salt-loslng) wlth thls mutation An 849-bp region ot CYP2l was ampl~f~ed by PCR util~z~ng a b~otlnylated prlmer Sequenc~ng was performed (Sequenaseh) foliowinq ~ynabead' maqnettc avid~n-blotln seoaratlon The presence of other reported mutatio.ns was assessed by hybrldizatlon 01 spec~tic ol~gonucleot~de probes Patlent 1 (46,XY) presented at 3 weeks of age w~th glucocorlico~d & mineralocortico~d def~clencles Patlent 2 (46,XX), asslglied to a male sex of rearlng at blrth. presented at 4 years of age wltll premature v~r~lization Patlent 3 (46,XX) presented at bin11 wltli anlblguous gen~talla and elevated plasma renln actlvity Pat~ents 1 8 3 have G at posltlon 655 on both CYP2l alleles whlle patlent 2 lnherlted a deletion for th~s regton from his mother & G lrorn IS father No sequence alteratlorls were detected In these 3 pattents from -160 to -80 of the 5' noncod~ng region of CYP2l Patlents 1 & 2 have the normal CYP21 sequence forcodons 172, 236, 237, 239. 306. 318, and 356 (analys~s IS ~ncomplete for patlent 3) D~nerences In regulation through TFs could be postulated as an etiology ot phenotyptc heterogeneity However. In these 3 patlents, the sequence where the adrenal speclf~c blndlng proteln lnleracts wltll DNA is conserved The bas6 forthe phenotypic heterogeneity may be due to as yet undefined alleratlons In the coding or pronioter reglons of CYP21 The sens~ttvfty ot th~s probe wiltch can easlfy detect 1 10.000 cells ~nd~cates that rnosalcrsm for the SRY portion ot the Y cllromosonie llas occurred In patients 1 8 3 For patients w~th Turner's syndrome. addltlonal Investigallon of such pal~enls 1s needed to determlne the frequency of th~s mosalclsm For patlent 3, the tjnd~ng of SRY gene correlates wllh the observed testlcular d~tterentlat~on and vlrll~zatlon For pallent 2, further evaluation of the function of SRY and addrt~onal genes ~nvolved In sexual ditterent~atlon a necessaly. The inability of hCG stimulation testtng to consistently identify testicular tissue prompted us to examine whether MIS, a sexually dimorphic hormone, would be useful i n evaluating children with nonpalpable gonads. W e measured M I S by E L l S A i n 7 46XY children and 3 chromosomal mosaics. 5.5 dysdstre:tk M I S , norm.~lly >lOngfml (boys) and <1.5ng/ml (girls) i n this age range, was mensurable i n 7 Dts with d v a~. lwtir or rrosslv n l testes but undetectablt: i n 2 ots with atrcak/&bseni gonads. M~S was uaeGl i n &xiding on explomtion of abdomiAal gonads for removal o f dysgenetic testes o r for orchiopexy. Thus, random M I S values were more discriminnlory for testicular tissue than basal testosterone levels and were specific for testicular tissue in 2 pts with nondcfinitive tiCC stim tests. The r e g u l a t o r y mechanisms o f adrenarche-and PA i n c l u d i n g t h e existence of a non-ACTH androgen s t i m u l a t i n g f a c t o r a r e ' c o n t r o v e r s i a l . W e sought t o e v a l u a t e t h e sup r e s s i b i l i t y o f t h e PA a x i s i n PA i n 24 c h i l d r e n (age 1.5-8.75 y r s ~M / Z O F , ) i n whom t h e dx o f PA was confir,med b ACTH t e s t i n ? . We me.asu;ed c o r t i s o l and andro en a t 8AM a f t e r a s t n g l e {M low dose o DEX 0 3mg/m2 given between ~IP$-MN [Hindmarsh and Brook, C l i n 
